Table 2 The characteristics of the patients stratified by treatment indication
|  | ICH(n = 78) | Seizure (n = 16) | p values |
|---|---|---|---|
Age | 47.53 ± 15.19 | 40.88 ± 18.01 | 0.146 |
Sex | |||
 Female | 44 | 11 | 0.526 |
 Male | 34 | 5 |  |
Craniotomy | 3 | 3 | 0.06 |
Interval from diagnosis to GKRS (months) | 4.51 ± 4.91 | 7.0 ± 6.18 | 0.038 |
Pre-existing neurological deficits | 41 | 0 | < 0.001 |
Familial Hx | 3 | 3 | 0.059 |
Multiple lesions | 21 | 7 | 0.231 |
Location | |||
 Brain stem | 20 | 0 | 0.017 |
 Deep seated | 31 | 5 |  |
 Subcortex | 27 | 11 |  |
Venous abnormality | 14 | 1 | 0.454 |
Target volume (TV) | 1.89 ± 3.64 | 2.11 ± 2.41 | 0.577 |
Margin dose (Gray) | 12 (11–12) | 12 (11–12) | 0.392 |
Physical component | 126.12 ± 33.60 | 154.84 ± 27.73 | 0.001 |
Mental component | 345.08 ± 77.92 | 382.50 ± 12.45 | 0.001 |
KPS | 64.97 ± 7.34 | 71.88 ± 4.03 | 0.01 |